About Us
ProteoGenix is a France-based biotech contract research organization (CRO) providing flexible end-to-end solutions for the discovery and development of life-saving biologics, precision diagnostic tools, and robust reagents for research. As a global leader in antibody, protein, peptide, and gene production, ProteoGenix aims at fostering the development of next-generation immunotherapies by focusing on developability. For more information, please visit www.proteogenix.science.
Press releases
ProteoGenix and Cizzle Biotechnology Collaboration Forges New Paths in...
Schiltigheim, France, April 25th, 2024 – ProteoGenix , a leading antibody development contract research organization (CRO), in a landmark... read more
29.04.2024 • By ProteoGenix
ProteoGenix Doubles R&D Facilities to Pave the Way for Minimal Animal...
New facilities support the fast growth and expansion of the phage display , antibody development, and bioproduction platform s... read more
07.07.2022 • By ProteoGenix
ProteoGenix Boosts the Discovery of Next-Generation Biotherapeutics and...
ProteoGenix today introduced a new single-domain naïve camelid antibody library (LiAb-VHHMAX TM ) designed to accelerate the development of... read more
01.07.2020 • By ProteoGenix
